OF
GILD icon

Optimize Financial’s Gilead Sciences GILD Stock Holding History

Optimize Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Sell
3,069
-10
-0.3% -$1.32K 0.14% 217
2026
Q1 		$429K Sell
3,079
-664
-18% -$93K 0.21% 175
2025
Q4 		$459K Buy
3,743
+52
+1% +$6.32K 0.23% 167
2025
Q3 		$410K Buy
+3,691
New +$420K 0.21% 204

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optimize Financial's GILD Position: Q2 2026 in Review

Optimize Financial reduced its Gilead Sciences (GILD) stake by 0.32% in Q2 2026, selling an estimated $1.32K and leaving 3,069 shares worth $388K. The position accounts for 0.14% of the portfolio, ranked #217.

Optimize Financial first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $459K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Optimize Financial held 3,069 shares of Gilead Sciences worth $388K as of Q2 2026.
  • Optimize Financial sold 10 Gilead Sciences shares in Q2 2026, an estimated $1.32K.
  • Gilead Sciences made up 0.14% of Optimize Financial's portfolio in Q2 2026, its #217 holding.
  • Optimize Financial first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Optimize Financial's Gilead Sciences position peaked at $459K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Optimize Financial's 13F filing for Q2 2026, filed 27 Aug 2026.